Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
1.200
0.00 (0.00%)
Nov 21, 2024, 4:00 PM EST - Market closed
Plus Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -12.89 | -13.32 | -20.28 | -13.4 | -8.24 | -10.89 | Upgrade
|
| Depreciation & Amortization | 0.8 | 0.75 | 0.71 | 0.42 | 0.37 | 0.43 | Upgrade
|
| Other Amortization | 0.05 | 0.19 | 0.39 | 0.55 | 0.58 | 1.78 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0 | - | 0.07 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.25 | 0.78 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.07 | - | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.56 | 0.57 | 0.61 | 0.61 | 0.25 | 0.13 | Upgrade
|
| Other Operating Activities | -2.11 | 0.08 | -0 | -0.01 | -2.29 | -3.4 | Upgrade
|
| Change in Accounts Receivable | 0.09 | - | - | - | 1.17 | -1.2 | Upgrade
|
| Change in Inventory | - | - | - | - | - | 0.26 | Upgrade
|
| Change in Accounts Payable | 1.71 | -3.68 | 6.45 | 1.73 | -1.23 | -0.03 | Upgrade
|
| Change in Unearned Revenue | 0.84 | 0.28 | 1.64 | - | - | 0.03 | Upgrade
|
| Change in Other Net Operating Assets | -0.22 | 2.28 | -2.5 | -0.5 | 0.18 | 0.01 | Upgrade
|
| Operating Cash Flow | -11.22 | -12.85 | -12.97 | -10.28 | -8.43 | -5.91 | Upgrade
|
| Capital Expenditures | -0.18 | -0.16 | -0.51 | -0.14 | -0.09 | -0.07 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.06 | - | - | Upgrade
|
| Divestitures | - | - | - | - | - | 5.64 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.55 | - | -0.25 | - | -0.4 | - | Upgrade
|
| Investing Cash Flow | -4.22 | -0.16 | -0.76 | -0.08 | -0.49 | 5.57 | Upgrade
|
| Long-Term Debt Repaid | - | -1.61 | -1.61 | -0.28 | -5.42 | -3.82 | Upgrade
|
| Net Debt Issued (Repaid) | -1.11 | -1.61 | -1.61 | -0.28 | -5.42 | -3.82 | Upgrade
|
| Issuance of Common Stock | 7.41 | 5.53 | 15.83 | 20.69 | 5.11 | 16.45 | Upgrade
|
| Repurchase of Common Stock | -0.5 | -0.13 | - | - | - | - | Upgrade
|
| Other Financing Activities | -0.15 | -0.35 | -0.77 | - | - | - | Upgrade
|
| Financing Cash Flow | 5.66 | 3.45 | 13.45 | 20.42 | -0.32 | 12.63 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | - | -0 | Upgrade
|
| Net Cash Flow | -9.78 | -9.57 | -0.28 | 10.05 | -9.25 | 12.29 | Upgrade
|
| Free Cash Flow | -11.4 | -13.01 | -13.48 | -10.42 | -8.53 | -5.97 | Upgrade
|
| Free Cash Flow Margin | -199.14% | -264.83% | -6018.30% | - | -2814.19% | -85.35% | Upgrade
|
| Free Cash Flow Per Share | -1.97 | -4.14 | -7.70 | -12.93 | -28.89 | -64.74 | Upgrade
|
| Cash Interest Paid | 0.04 | 0.22 | 0.33 | 0.39 | 0.57 | 1.19 | Upgrade
|
| Levered Free Cash Flow | -6.32 | -8.31 | -8.21 | -5.18 | -5.13 | 0.74 | Upgrade
|
| Unlevered Free Cash Flow | -6.26 | -8.26 | -8.15 | -5.14 | -5.03 | 1.35 | Upgrade
|
| Change in Net Working Capital | -2.68 | 1.09 | -3.61 | -1.59 | -0.36 | -1.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.